Bupropion (Wellbutrin): What to Know in 2026
Bupropion is an atypical antidepressant that works on norepinephrine and dopamine instead of serotonin. Here is its distinctive profile versus SSRIs, plus the seizure risk and safety cautions that shape how it is prescribed.
By WeighedHealth Editorial
6 min readUpdated
- ~0.0%
- Seizure incidence at bupropion SR doses up to 300 mg per day
- ~0.0%
- Seizure incidence with immediate-release at 300 to 450 mg per day
- 05
- Year bupropion was first approved in the United States
- Under 0
- Age group flagged in the antidepressant boxed warning for suicidality risk
Jump to section
The short version
Bupropion (brand name Wellbutrin) is an atypical antidepressant that works differently from SSRIs. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and has almost no direct action on serotonin, which explains its distinctive side-effect profile [1]. It is FDA-approved for major depressive disorder and for seasonal affective disorder, and the same molecule is sold as Zyban for smoking cessation [1]. Compared with SSRIs it is usually weight-neutral or causes slight weight loss, rarely causes sexual side effects, and tends to be activating rather than sedating [3][4]. Its main catch is a dose-related seizure risk, which is why it is contraindicated in people with seizure disorders, eating disorders, and certain withdrawal states [1].
What bupropion is and how it works
Bupropion is one of the oldest second-generation antidepressants, first approved in the United States in 1985 [2]. Chemically it is unrelated to SSRIs, SNRIs, and tricyclics. It blocks the reuptake of norepinephrine and dopamine, raising the levels of those two neurotransmitters between neurons, and it does not meaningfully block serotonin reuptake [1]. That single mechanistic difference drives most of what makes the drug stand out in practice.
Because it leaves the serotonin system largely alone, bupropion sidesteps several of the effects that patients most often dislike about SSRIs. It also means the two drug classes can be combined by a prescriber, since they act on different systems. Doctors sometimes add bupropion to an SSRI to treat residual symptoms or to try to offset SSRI side effects, though the evidence for that second use is limited [4].
How it differs from SSRIs
Three traits set bupropion apart. First, weight. Many antidepressants promote weight gain over months of use, while bupropion is one of the few consistently linked to weight neutrality or modest weight loss. A large meta-analysis of antidepressants and body weight grouped bupropion with the agents least likely to add pounds [3].
Second, sexual side effects. SSRIs commonly reduce libido, delay orgasm, or cause erectile difficulty. Bupropion has a much lower rate of these problems, which is a major reason it gets prescribed to people who stopped an SSRI over sexual side effects [4]. It is also sometimes added to an ongoing SSRI to try to reverse those effects, but controlled trials of that strategy have been mixed, so it is not a guaranteed fix [4].
Third, it is generally activating rather than sedating. Bupropion can increase energy and reduce fatigue, and it is usually taken in the morning to avoid insomnia. The flip side is that in some people it causes jitteriness, anxiety, or trouble sleeping, especially early in treatment.
What it is approved to treat
Bupropion carries FDA approval for two psychiatric uses: major depressive disorder and the prevention of seasonal major depressive episodes in seasonal affective disorder [1]. The extended-release (XL) form is the one specifically approved for the seasonal indication.
The exact same active ingredient is marketed under a different brand name, Zyban, and is FDA-approved as an aid to smoking cessation [1]. That is why a person may be offered bupropion whether they come in for depression or to quit smoking. Beyond these labeled uses, clinicians also prescribe it off-label for conditions such as adult ADHD, but off-label use is a decision for the prescriber and is not covered by the FDA approval.
The seizure risk and who should not take it
The defining safety concern with bupropion is that it lowers the seizure threshold, and that risk rises with dose. At sustained-release doses up to 300 mg per day, the seizure incidence is roughly 0.1%, about 1 in 1,000 [2]. With the older immediate-release form at 300 to 450 mg per day, prospective data showed about 0.4%, and the risk climbs sharply above the maximum recommended dose [2]. Staying within labeled dose limits and using slow-release formulations keeps the risk low for most people.
Because of this, bupropion is contraindicated in several situations: a current or prior seizure disorder; a current or prior diagnosis of bulimia or anorexia nervosa, where electrolyte disturbances further raise seizure risk; and abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs [1]. It also must not be combined with an MAO inhibitor or taken within 14 days of stopping one [1]. Anyone with these conditions should make sure their clinician knows before bupropion is considered.
The boxed warning and other cautions
Like all antidepressants, bupropion carries an FDA boxed warning that these drugs can increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults under 25, particularly in the first weeks of treatment or after a dose change [1]. Patients of all ages starting the drug should be watched for worsening mood, agitation, or emerging suicidal thinking, and anyone experiencing those signs should contact their prescriber promptly.
Other effects worth knowing include increased blood pressure, dry mouth, headache, nausea, insomnia, and in some people anxiety or restlessness. Because bupropion is stimulating, it can unmask or worsen agitation and, rarely, trigger manic episodes in people with bipolar disorder. Dose changes and stopping the medication should always be managed by the prescribing clinician rather than done on your own.
IR, SR, and XL: why the formulation matters
Bupropion comes in three release forms, and they are not interchangeable milligram for milligram in how they are dosed. Immediate-release (IR) tablets are taken multiple times a day and carry the highest peak levels. Sustained-release (SR) is taken twice daily. Extended-release (XL) is taken once daily and produces the flattest peaks [1].
The trend toward SR and XL is partly a safety story: spreading the drug out over the day lowers peak concentrations, which is thought to reduce seizure risk compared with the same total dose given as fast-acting IR [2]. The formulation also determines the maximum single and daily dose your clinician can use, so switching between forms is a prescribing decision, not something to adjust on your own.
How it is actually prescribed
In practice, a clinician typically starts bupropion low and increases gradually, staying within the labeled maximum for the specific formulation to keep seizure risk minimal. They will screen first for seizure history, eating disorders, heavy alcohol or sedative use, and bipolar disorder, since those change whether the drug is safe. Because it is activating, it is usually dosed earlier in the day.
Bupropion is a reasonable option for someone who wants to avoid the weight gain or sexual side effects common with SSRIs, or who is treating depression and wants to quit smoking at the same time. It is a poor fit for someone with a seizure disorder or an eating disorder. The right choice depends on your full history, so the decision to start, adjust, or stop belongs with a prescribing clinician who knows your case.
Sources
Primary sources cited above. FDA labeling, peer-reviewed trials, and specialty-society guidelines only.
- WELLBUTRIN XL (bupropion hydrochloride extended-release tablets) Prescribing Information · U.S. Food and Drug Administration, 2022
- WELLBUTRIN (bupropion hydrochloride) Tablets Prescribing Information (seizure incidence by formulation and dose) · U.S. Food and Drug Administration, 2007
- Antidepressants and body weight: a comprehensive review and meta-analysis · Journal of Clinical Psychiatry, 2010 · PMID 21062615
- Bupropion in the depression-related sexual dysfunction: a systematic review · CNS & Neurological Disorders - Drug Targets, 2014 · PMID 24923342
People also ask
Is bupropion an SSRI?
No. Bupropion is not an SSRI and works on entirely different neurotransmitters. It is classified as a norepinephrine-dopamine reuptake inhibitor (NDRI), meaning it raises norepinephrine and dopamine levels while leaving serotonin largely untouched. SSRIs, by contrast, act specifically on serotonin. This difference is why bupropion has a distinct side-effect profile, with less sexual dysfunction and less weight gain than typical SSRIs but a dose-related seizure risk that SSRIs do not carry in the same way. Because the two classes act on different systems, a prescriber can sometimes use them together, though that is a clinical decision.
Does bupropion cause weight gain?
Usually not. Bupropion is one of the few antidepressants consistently linked to weight neutrality or slight weight loss rather than gain. A large meta-analysis of antidepressants and body weight placed bupropion among the agents least likely to add weight, in contrast to drugs like paroxetine and mirtazapine, which are associated with more weight gain over time. Individual responses vary, and some people notice no change at all. It is not approved as a weight-loss drug on its own, though bupropion is a component of one prescription weight-management combination. Any use for weight should be directed by a clinician.
Why does bupropion have a seizure risk?
Bupropion lowers the seizure threshold, and the risk rises with dose. At sustained-release doses up to 300 mg per day the incidence is about 0.1%, roughly 1 in 1,000, and it increases at higher doses and with the immediate-release form. Because of this, it is contraindicated in people with a current or past seizure disorder, in those with bulimia or anorexia, and during abrupt withdrawal from alcohol, benzodiazepines, or sedatives, all of which further raise seizure risk. Staying within the labeled maximum dose and using slow-release formulations keeps the risk low for most people. Tell your prescriber about any of these conditions before starting.
Is bupropion used for smoking cessation?
Yes. The same active ingredient in Wellbutrin is FDA-approved under the brand name Zyban as an aid to quitting smoking. It can reduce cravings and withdrawal symptoms and is often started a week or two before a planned quit date. Because it is the identical molecule, someone treating both depression and nicotine dependence may be offered bupropion to address both at once. The same cautions apply, including the seizure contraindications and the antidepressant boxed warning. Whether Zyban or Wellbutrin is prescribed, it should not be combined with a second bupropion product, since that would stack the dose and raise seizure risk.
Does bupropion cause sexual side effects?
Bupropion has a much lower rate of sexual side effects than SSRIs, which commonly reduce libido and delay orgasm. That is one of the main reasons it is chosen for people who stopped an SSRI over sexual problems. It is also sometimes added to an existing SSRI to try to reverse those effects, but controlled trials of that add-on strategy have produced mixed results, so it is not a reliable fix. If sexual side effects are a priority for you, discuss it with your prescriber, who can weigh bupropion against other options based on your full history rather than treating it as guaranteed.
Is bupropion activating or sedating?
Bupropion is generally activating rather than sedating. Many people notice more energy and less fatigue, which is helpful for depression that comes with low motivation. Because of this, it is usually taken in the morning to avoid interfering with sleep. The trade-off is that some people experience insomnia, jitteriness, restlessness, or anxiety, especially in the first weeks. In people with bipolar disorder, its stimulating effect can rarely trigger mania, so a clinician will screen for that history. If insomnia or anxiety appears after starting, do not stop the drug on your own; contact your prescriber, who can adjust timing or dose.
What is the difference between IR, SR, and XL bupropion?
They are the same drug in different release forms. Immediate-release (IR) is taken several times a day and produces the highest peak levels. Sustained-release (SR) is taken twice daily. Extended-release (XL) is taken once daily and gives the flattest, most even levels. Spreading the drug out lowers peak concentrations, which is thought to reduce seizure risk compared with the same total dose as fast-acting IR. The three forms also have different maximum doses, so they are not interchangeable milligram for milligram. Switching between them is a prescribing decision, not something to adjust yourself.
Who should not take bupropion?
Bupropion is contraindicated in several groups. People with a current or past seizure disorder should not take it, nor should those with a current or prior diagnosis of bulimia or anorexia nervosa, because both raise seizure risk. It must not be used during abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiseizure drugs. It also cannot be combined with an MAO inhibitor or taken within 14 days of stopping one. People with bipolar disorder need careful screening because of mania risk. As with all antidepressants, a boxed warning covers increased suicidal thinking in people under 25. Share your full history with your prescriber.
Related reads
Escitalopram (Generic Lexapro): What It Is and How It's Used
Escitalopram is the generic of Lexapro, an SSRI approved for depression and anxiety. How it works, dosing, onset, side effects, the under-25 boxed warning, and safe stopping.
Propranolol for Performance Anxiety: What It Does and Doesn't Do (2026)
Propranolol is a beta-blocker used off-label for stage fright and performance nerves. It blunts the physical adrenaline symptoms like racing heart and shaky hands, but it does not treat the worry itself or chronic anxiety, and it carries real heart and lung contraindications.